- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02025296
Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care
Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of telemedicine (also known as connected health, e-health, or telehealth) has been proven to be beneficial in chronic disease management. Now, the classic concept of telemedicine has been evolving to ubiquitous (u)-healthcare system with advanced information technologies which provides real-time individualized feedback using a monitoring device attached to the internet or a mobile phone system.
A few studies showed that adopting a u-healthcare system helped patients improve their blood glucose control and reduced hypoglycemia or weight gain. In a previous study, supervised telemonitoring was effective for blood pressure control in hypertensive patients in primary care settings. A recent study showed that telemonitoring with pharmacist's help achieved better blood pressure control compared with usual care during 12 months of intervention.
A clinical decision support system (CDSS) is the key to this system, building up an individualized CDSS rule engine is the crux of the u-healthcare system because current glucose control status, antidiabetic medications, lifestyle, and severity of hypoglycemia vary between individual patients.
Recently, our u-healthcare team generated a new multidisciplinary u-healthcare system by upgrading the CDSS rule engine, and integrating a physical activity-monitoring device and dietary feedback into a comprehensive package. With this integrated system, we investigate the effect of individualized multidisciplinary u-healthcare service combined with exercise monitoring and dietary feedback on glucose control with less hypoglycemia in Korean elderly population.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gyeonggi
-
Seongnam, Gyeonggi, Korea, Republic of, 463-707
- SNUBH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with type 2 diabetes mellitus
- Glycated hemoglobin (HbA1c) levels: 7.0-10.5%
Exclusion Criteria:
- Patients who were unable to use text messages or to access the internet for any reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Self-Monitoring of Blood Glucose
measurement of their blood glucose level using a glucometer at least eight times a week
|
|
Experimental: U-healthcare
individualized multidisciplinary u-healthcare service combined with exercise monitoring and dietary feedback on glucose control
|
use of a public switched telephone network (PSTN)-connected glucometer to measure their blood glucose level at the same frequency as the SMBG group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
proportion of patients achieving the target of HbA1c <7% without hypoglycemia
Time Frame: 6 months
|
The primary endpoint of the present study was the proportion of patients achieving the target of HbA1c <7% without hypoglycemia at 6 months.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hypoglycemia
Time Frame: 6 months
|
Numbers of hypoglycemic events
|
6 months
|
Obesity index
Time Frame: 6 months
|
Changes of BMI and Waist circumference
|
6 months
|
Lifestyle
Time Frame: 6 months
|
Changes of caloric intake and exercise
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Soo Lim, MD, PhD, SNUBH
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- U-healthcare system
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus With Hypoglycemia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
George E. DafoulasUniversity of Ioannina; Centre for Research and Technology HellasRecruitingDiabetes Mellitus Type 2 With HypoglycemiaGreece
-
Medical University of GrazMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Hypoglycemia | Diabetes Mellitus With Hypoglycemia | Hypoglycemic EpisodeAustria
-
University of LincolnCompletedDiabetes Mellitus Type 2 With HypoglycemiaJordan
-
Seoul National University HospitalCompletedType 2 Diabetes Mellitus With HypoglycemiaKorea, Republic of
-
University of HullCompletedType 2 Diabetes Mellitus With HypoglycemiaUnited Kingdom
-
Imperial College LondonCompletedType1diabetes | Type 1 Diabetes Mellitus With Hypoglycemia | Impaired Awareness of Hypoglycemia
-
Kaiser PermanenteNational Institute on Aging (NIA)RecruitingAging | Patient Activation | Type 2 Diabetes Mellitus With HypoglycemiaUnited States
-
Oregon Health and Science UniversityRecruiting
-
University of EdinburghNHS Lothian; DexCom, Inc.; Tandem Diabetes Care, Inc.; The Leona M. and Harry B...Active, not recruitingHypoglycemia | Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia | Hypoglycemia Unawareness | Glucagon Deficiency | Insulin HypoglycemiaUnited Kingdom
Clinical Trials on U-healthcare
-
Seoul National University Bundang HospitalCompletedDiabetesKorea, Republic of
-
SK Telecom ConsortiumCompletedDiabetes MellitusKorea, Republic of
-
M.D. Anderson Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
National Taiwan University HospitalRecruitingCancer | Drug-Related Side Effects and Adverse Reactions | Cancer, Treatment-Related | EGFR Gene MutationTaiwan
-
University of Colorado, DenverPatient-Centered Outcomes Research Institute; Mayo Clinic; University of Michigan and other collaboratorsRecruitingCommunication DisabilitiesUnited States
-
Desmond Tutu HIV FoundationNational Institute of Mental Health (NIMH); University of Pennsylvania; National...RecruitingHIV Infections | Treatment Adherence | MenSouth Africa
-
Kutahya Health Sciences UniversityCompleted
-
Mansoura University Children HospitalCompletedRespirtory DistressEgypt
-
Fred Hutchinson Cancer CenterRecruitingHuman Papillomavirus-Related CarcinomaUnited States
-
Leibniz-Institut für Resilienzforschung (LIR) gGmbHEuropean Regional Development Fund; Ministry of Science and Health of Rhineland-Palatinate... and other collaboratorsRecruiting